| Autor: |
Ferguson, A.W., Scott, J.A., McGavigan, J., Elton, R.A., McLean, J., Schmidt, U., Kelkar, R., Dhillon, B. |
| Předmět: |
|
| Zdroj: |
British Journal of Ophthalmology; Feb2003, Vol. 87 Issue 2, p163, 5p, 1 Diagram, 1 Chart, 2 Graphs |
| Abstrakt: |
Aims: To determine if macrolide resistant Streptococcus pneumoniae will be a major concern in areas that receive annual mass azithromycin distributions for trachoma. Methods: A cross sectional survey was conducted of nasopharyngeal S pneumoniae isolates for susceptibility to azithromycin 1 year after administering a single dose of azithromycin to treat trachoma in a village in Nepal. Results: S pneumoniae was isolated from 50 (86%) of 57 nasopharyngeal cultures and no resistance to azithromycin was detected. Conclusion: The authors were unable to demonstrate that mass azithromycin therapy for trachoma produced macrolide resistant S pneumoniae that persists until the next scheduled annual treatment. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
